Starting at midnight on January 1, recreational marijuana became legal in California. Cannabis for medicinal purposes has been legal for more than two decades, but this legislation signals a change for the industry.
Alyssa Julya Smith caught up with MedMen Dispensary's CMO BJ Carretta to discuss the economic impact, and where some of the tax dollars will go from an industry poised to make $7 billion in the coming years.
MedMen is one of only three dispensaries in Los Angeles that has received a license on January 1 to sell recreational cannabis products as the city and state are slowly rolling them out.
Carretta talks about de-stigmatizing the practice of cannabis use, and how that will help grow the industry to one of the biggest in the Golden State. He also says marijuana taxes will be as high as 35%, and the state is still figuring out what will be done with the tax money made off of the sales.
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
Two of the top low-cost online retailers are going head to head in a new legal battle. Cheddar News' Michelle Castillo breaks the lawsuit down.
The number of Americans filing for jobless benefits fell last week as the labor market continues to thrive despite high interest rates and elevated costs.
The earliest version of Disney's Mickey Mouse will become public domain on Jan. 1, 2024.
The toy magic oven called the Cookeez Makery is one of the hottest toys for kids this holiday season.
In the UK, IKEA is looking to give away some meatballs, and not just regular-size meatballs.
Dwayne 'The Rock' Johnson is set to star in a movie playing MMA and UFC legend, Mark Care, while Kevin Hart will headline a boxing project over on Peacock.
Coca-Cola is recalling drinks sold in three southern states due to possible "foreign materials" inside cans.
Stocks jumped after the Dow Jones closed at a record high while fresh retail sales data showed positive consumer spending ahead of the holidays.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
